ConductScience.org, home

Paper913025

Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.

Pond SM and 2 others. Clin Pharmacol Ther, 1977. Cited by 89 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole. Papers, record 913025. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/913025

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
4.1
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pond SMS M
2Birkett DJD J
3Wade DND N

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OxyphenbutazoneMajor topic
PhenylbutazoneMajor topic
SulfaphenazoleMajor topic
TolbutamideMajor topic
Adult
Depression, Chemical
Drug Interactions
Half-Life
Humans
Male
Time Factors

Source PubMed

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
30,910,785An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials.Drug Metab Dispos2019https://conductscience.org/library/papers/30910785PubMed
29,119,333Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam.Eur J Drug Metab Pharmacokinet2018https://conductscience.org/library/papers/29119333PubMed
21,234,089Matching the Drug to the Patient: The rational use of antiarthritic drugs.Can Fam Physician1991https://conductscience.org/library/papers/21234089PubMed
19,214,275Applying organ clearance concepts in a clinical setting.Am J Pharm Educ2008https://conductscience.org/library/papers/19214275PubMed
11,678,793Systemic bioavailability of fluticasone proprionate.Br J Clin Pharmacol2001https://conductscience.org/library/papers/11678793PubMed
10,991,840Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10991840PubMed
9,663,807Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9663807PubMed
9,160,172Clinical pharmacokinetics of tretinoin.Clin Pharmacokinet1997https://conductscience.org/library/papers/9160172PubMed
9,068,933A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide.Clin Pharmacokinet1997https://conductscience.org/library/papers/9068933PubMed
8,452,660Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.Drug Saf1993https://conductscience.org/library/papers/8452660PubMed
8,424,795Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.Biochem J1993https://conductscience.org/library/papers/8424795PubMed
8,186,538Nonsteroidal anti-inflammatory drugs. Differential use in older patients.Drugs Aging1994https://conductscience.org/library/papers/8186538PubMed
8,186,058Plasma protein binding displacement interactions--why are they still regarded as clinically important?Br J Clin Pharmacol1994https://conductscience.org/library/papers/8186058PubMed
7,741,982Antihyperglycaemic agents. Drug interactions of clinical importance.Drug Saf1995https://conductscience.org/library/papers/7741982PubMed
7,437,261A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7437261PubMed
7,213,531Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7213531PubMed
7,175,701Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.J Pharmacokinet Biopharm1982https://conductscience.org/library/papers/7175701PubMed
7,106,168The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7106168PubMed
7,030,708Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.Drugs1981https://conductscience.org/library/papers/7030708PubMed
6,860,533Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6860533PubMed

See all 33 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP4F34,051PubTator's text mininghttps://conductscience.org/library/genes/4051

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/913025

GET https://conductscience.org/api/papers/v1/913025/cited_by?page=2